Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04291131 · ClinicalTrials.gov registry record

BRAIN, Symptoms, and Physical Activity in COPD

A clinical trial of COPD and Chronic Musculoskeletal Pain, sponsored by VA Office of Research and Development.

Completed
Registry status
9
Enrollment target
1
Study location

NCT04291131: Completed study of COPD and Chronic Musculoskeletal Pain, sponsored by VA Office of Research and Development.

NCT04291131 is a study of COPD and Chronic Musculoskeletal Pain that has completed, run by VA Office of Research and Development. The registered enrollment target is 9 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04291131, a study of COPD and Chronic Musculoskeletal Pain, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
9 participants
Enrollment target
1
Study location

Study Summary

Persons with COPD have both chronic musculoskeletal pain and dyspnea that require accurate diagnosis and treatment, ultimately to optimize functional status. The investigators propose to use advanced neuroimaging techniques to understand central mechanisms of chronic pain, dyspnea, and physical activity promotion in COPD. The investigators' novel proposal to correlate subjective symptoms (chronic pain and dyspnea) with an objective central biomarker (resting state functional connectivity) and examine their changes in response to a non-pharmacological, non-addictive physical activity intervention will personalize the care of Veterans with COPD.

Primary Outcome

Cortical thickness will be measured by brain MRIs that will assess functional connectivity and structural variables. Cortical thickness will be reported in millimeters.

Study Locations (1)

Massachusetts

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2020-07-01
Est. Completion 2024-06-30
VA Office of Research and Development

1,668 total trials

What the finished NCT04291131 record still lists

NCT04291131 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with COPD appearing as the primary indexed condition, and to 0 interventions.

NCT04291131 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04291131 about?

NCT04291131 is a clinical study titled "BRAIN, Symptoms, and Physical Activity in COPD". Persons with COPD have both chronic musculoskeletal pain and dyspnea that require accurate diagnosis and treatment, ultimately to optimize functional status. The investigators propose to use advanced neuroimaging techniques to understand central mechanisms of chronic pain, dyspnea, and physical acti...

What is the current status of trial NCT04291131?

This trial is currently completed. The enrollment target is 9 participants. The study started on 2020-07-01. Estimated completion is 2024-06-30.

What conditions does trial NCT04291131 study?

This clinical trial studies the following conditions: COPD, Chronic Musculoskeletal Pain.

Who is sponsoring clinical trial NCT04291131?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04291131 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COPD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04291131's enrollment target sits among peer trials

9 84th of 85 higher than 2 of 85 other COPD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04291131, the US trial registry maintained by the National Library of Medicine. NCT04291131 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.